Skip to main content
SpringerLink
Log in

The World of Resveratrol

  • Chapter
Nutrition and Cancer Prevention

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 492))

Abstract

Since the discovery of trans-resveratrol (3,5,4’-trihydroxystilbene) as a constituent of wine by Siemann and Creasy, first reported in 1992 (1), the possibility that this compound, almost unique to red wine among constituents of the human diet, may in large measure account for the putative health benefits of this beverage beyond its mere content of vulgar ethanol, excited the imagination of the scientific and medical communities, initiating a ferment of research and enquiry that continues to this day. Indeed, ripples of these activities from time to time flow into the pages of the lay press, so that resveratrol has become a molecule impacting the consciousness of many well-informed members of the lay public. In March, 1997 we published a major review incorporating 183 references forming the bulk of the world literature on resveratrol up to that time (2). Our bottom line was that the future of resveratrol did not look particularly promising given the reality that, despite its miraculous performances in the culture dish and the test tube, the intact bodies of mice and men proved to be an inhospitable millieu robbing it of its presumed powers. To us, it seemed to be a compound for whom the bell tolled , but others did not share this gloomy prognosis. In fact, so much new work on this topic has been published in a mere two years-and-a-bit that a reappraisal of the situation deserves a welcome and is mandated by the present Symposium. Resveratrol exists as trans and cis isomers. Very little is known about the latter. When the nature of resveratrol is not specified, the reader should assume that the text refers to the trans isomer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Siemann EH, Creasy LL. Concentration of the phytoalexin resveratrol in wine. Am J Enol Vitic 1992; 43:49–52.

    CAS  Google Scholar 

  2. Soleas GJ, Diamandis EP, Goldberg DM. Resveratrol: A molecule whose time has come? And gone? Clin Biochem 1997; 30:91–113.

    Article  PubMed  CAS  Google Scholar 

  3. Daniel O, Meier MS, Schlatter J, Frischknecht P. Selected phenolic compounds in cultivated plants: Ecologic functions, health implications, and modulation of pesticides. Environ Health Perspect 1999; 107 Suppl 1:109–114.

    Article  PubMed  CAS  Google Scholar 

  4. Constant J. Alcohol, ischemic heart disease, and the French paradox. Coron Artery Dis 1997; 8:645–649.

    Article  PubMed  CAS  Google Scholar 

  5. Ross R. Atherosclerosis - An inflammatory disease. N Engl J Med 1999; 340:115–126.

    Article  PubMed  CAS  Google Scholar 

  6. Nicholson AC, Najjar DP. Herpesviruses in atherosclerosis and thrombosis: etiologic agents or ubiquitous bystanders? Arterioscler Thromb Vasc Biol 1998; 18:339–348.

    Article  PubMed  CAS  Google Scholar 

  7. Jang M, Cai L, Udeani GO et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997; 275:218–220.

    Article  PubMed  CAS  Google Scholar 

  8. Subbaramaiah K, Chung WJ, Michaluart P et al. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Bic J Chem 1998; 273:21875–21882.

    Article  CAS  Google Scholar 

  9. Jang M, Pezzuto JM. Effects of resveratrol on 12-O-tetradecanoylphorbol-13acetate-induced oxidative events and gene expression in mouse skin. Cancer Lett 1998; 134:81–89.

    Article  PubMed  CAS  Google Scholar 

  10. Jong M, Pezzuto JM. Cancer chemopreventive activity of resveratrol. Drugs Exp Clin Res 1999; 25:65–77.

    Google Scholar 

  11. Mizutani K, Ikeda K, Kawai Y, Yamori Y. Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3–E1 cells. Biochem Biophys Res Commun 1998; 253:859–863.

    Article  PubMed  CAS  Google Scholar 

  12. Johnson JL, Maddipati KR. Paradoxical effects of resveratrol on the two prostaglandin H synthases. Prostaglandins Other Lipid Mediat 1998;56:131–143.

    Article  PubMed  CAS  Google Scholar 

  13. Lee SH, Shin NH, Kang SH et al. Alpha-viniferin: a prostaglandin H2 synthase inhibitor from root of Carex humilis. Planta Med 1998; 64:204–207.

    Article  PubMed  CAS  Google Scholar 

  14. Shin NH, Ryu SY, Lee H, Min KR, Kim Y. Inhibitory effects of hydroxystilbenes on cyclooxygenase from sheep seminal vesicles. Planta Med 1998; 64:283–284.

    Article  PubMed  CAS  Google Scholar 

  15. Knight J, Taylor GW, Wright P, Clare AS, Rowley AF. Eicosanoid biosynthesis in an advanced deuterostomate invertebrate, the sea squirt (Ciona intestinalis). Biochim Biophys Acta 1999; 1436:467–478.

    Article  PubMed  CAS  Google Scholar 

  16. Kawada N, Seki S, Inoue M, Kuroki T. Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells. Hepatology 1998; 27:1265–1274.

    Article  PubMed  CAS  Google Scholar 

  17. Chen T, Li J, Cao J, Xu Q, Komatsu K, Namba T. A new flavanone isolated from rhizoma smilacis glabrae and the structural requirements of its derivatives for preventing immunological hepatocyte damage. Planta Med 1999; 65:56–59.

    Article  PubMed  CAS  Google Scholar 

  18. Kimura Y, Okuda H, Arichi S. Effects of stilbenes on arachidonate metabolism in leukocytes. Biochim Biophys Acta 1985; 834:275–278.

    Article  PubMed  CAS  Google Scholar 

  19. Goldberg DM, Soleas GJ, Hahn SE, Diamandis EP, Karumanchiri A. Identification and assay of trihydroxystilbenes in wine and their biological properties. In: Watkins T, ed. Wine composition and health benefits. American Chemical Society, Washington DC, 1997; pp. 24–43.

    Google Scholar 

  20. Kimura Y, Okuda H, Kubo M. Effects of stilbenes isolated from medicinal plants on arachidonate metabolism and degranulation in human polymorphonuclear leukocytes. J Ethnopharmacol 1995; 45:131–139.

    Article  PubMed  CAS  Google Scholar 

  21. Shan CW. Effects of polydatin on platelet aggregation of rabbits. Acta Pharmacol Sin 1988; 23:394–396.

    CAS  Google Scholar 

  22. Shan CW, Yang SQ, He HD, Shao SL, Zhang PW. Influences of 3,4,5-trihydroxy stilbene-3-J -mono-D-glucoside on rabbits’ platelet aggregation and thromboxane B2 production in vitro. Acta Pharmacol Sin 1990; 11:527–530.

    CAS  Google Scholar 

  23. Chung M-I, Teng C-M, Cheng K-L, Ko F-N, Lin C-N. An antiplatelet principle of Veratrum formosanum. Planta Med 1992; 58:274–276.

    Article  PubMed  CAS  Google Scholar 

  24. Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart disease. Clin Chim Acta 1995; 235:207–219.

    Article  PubMed  CAS  Google Scholar 

  25. Bertelli AAE, Giovannini L, Gianncssi D. et al. Antiplatelet activity of synthetic and natural resveratrol in red wine. Int J Tiss React 1995; 17:1–3.

    CAS  Google Scholar 

  26. Bertelli AAE, Giovannini L, De Caterina R. et al. Antiplatelet activity of cis resveratrol. Drugs Exp Clin Res 1996; 22:61–63.

    PubMed  CAS  Google Scholar 

  27. Orsini F, Pelizzoni F, Verotta L, Aburjai T, Rogers CB. Isolation, synthesis, and antiplatelet aggregation activity of resveratrol 3-O-beta-D-glucopyranoside and related compounds. J Nat Prod 1997; 60:1082–1087.

    Article  PubMed  CAS  Google Scholar 

  28. Cavenagh JD, Cahill MR, Kelsey SM. Adhesion molecules in clinical medicine. Crit Rev Clin Lab Sci 1998; 34:415–459.

    Article  Google Scholar 

  29. Chia MC. The role of adhesion molecules in atherosclerosis. Crit Rev Clin Lab Sci 1998; 35:573–602.

    Article  PubMed  CAS  Google Scholar 

  30. Ferrero ME, Bertelli AE, Fulgenzi A. et al. Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium. Am J Clin Nutr 1998; 68:1208–1214.

    PubMed  CAS  Google Scholar 

  31. Rotondo S, Rajtar G, Manarini S et al. Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. Br J Pharmacol 1998; 123:1691–1699.

    Article  PubMed  CAS  Google Scholar 

  32. Cheong H, Ryu SY, Kim KM. Anti-allergic action of resveratrol and related hydroxystilbenes. Planta Med 1999; 65:266–268.

    Article  PubMed  CAS  Google Scholar 

  33. Tsai SH, Lin-Shiau SY, Lin JK. Suppression of nitric oxide synthase and the down-regulation of the activation of NfkappaB in macrophages by resveratrol. Br J Pharmacol 1999; 126:673–680.

    Article  PubMed  CAS  Google Scholar 

  34. Wadsworth TL, Koop DR. Effects of the wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages. Biochem Pharmacol 1999; 57:941–949.

    Article  PubMed  CAS  Google Scholar 

  35. Draczynska-Lusiak B, Chen YM, Sun AY. Oxidized lipoproteins activate NFkappaB binding activity and apoptosis in PC12 cells. Neuroreport 1998; 9:527–532.

    Article  PubMed  CAS  Google Scholar 

  36. Pendurthi UR, Williams JT, Rao LV. Resveratrol, a polyphenolic compound found in wine, inhibits tissue factor expression in vascular cells: A possible mechanism for the cardiovascular benefits associated with moderte consumption of wine. Arerioscler Thromb Vase Biol 1999; 19:419–426.

    Article  CAS  Google Scholar 

  37. Casper RF, Quesne M, Rogers IM et al. Resveratrol has antagonist activity on the aryl hydrocarbon receptor: Implications for prevention of dioxin toxicity. Mol Pharmacol 1999; In Press.

    Google Scholar 

  38. Arichi H, Kimura Y, Okuda H, Baba K, Kozawa M, Arichi S. Effects of stilbene components of the roots of Polygonum cuspidatum Sieb. et Zucc. on lipid metabolism. Chem Pharm Bull 1982; 30:1766–1770.

    Article  PubMed  CAS  Google Scholar 

  39. Goldberg DM, Hahn SE, Parkes, JG. Beyond alcohol: Beverage consumption and cardiovascular mortality. Clin Chim Acta 1995; 237:155–187.

    Article  PubMed  CAS  Google Scholar 

  40. Goldberg DM, Garovic-Kocic V, Diamandis EP, Pace-Asciak, CR. Wine: does the colour count? Clin Chim Acta 1996; 246:183–193.

    Article  PubMed  CAS  Google Scholar 

  41. Turrens JF, Lariccia J, Nair MG. Resveratrol has no effect on lipoprotein profile and does not prevent peroxidation of serum lipids in normal rats. Free Radic Res 1997; 27:557–62.

    Article  PubMed  CAS  Google Scholar 

  42. Wilson T, Knight Ti, Beitz DC, Lewis DS, Engen RL. Resveratrol promotes atherosclerosis in hypercholesterolemic rabbits. Life Sci 1996; 59:15–21.

    Article  Google Scholar 

  43. Uenobe F, Nakamura S-I, Miyazawa M. Antimutagenic effect of resveratrol against Trp-P-1. Mutat Res 1997; 373:197–200.

    Article  PubMed  CAS  Google Scholar 

  44. Mgbonyebi OP, Russo J, Russo IH. Antiproliferative effect of synthetic resveratrol on human breast epithelial cells. Int J Oncol 1998; 12:865–869.

    PubMed  CAS  Google Scholar 

  45. ElAttar TM, Virji AS. Modulating effect of resveratrol and quercetin on oral cancer cell growth and proliferation. Anticancer Drugs 1999; 10:187–193.

    Article  PubMed  CAS  Google Scholar 

  46. Hsieh TC, Wu JM. Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. Exp Cell Res 1999; 249:109–115.

    Article  PubMed  CAS  Google Scholar 

  47. Carbo N, Costelli P, Baccino FM, Lopez-Soriano FJ, Argiles JM. Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model. Biochem Biophys Res Commun 1999; 254:739–743.

    Article  PubMed  CAS  Google Scholar 

  48. Clement MV, Hirpara JL, Chawdhury SH, Pervaiz S. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 1998; 92:996–1002.

    PubMed  CAS  Google Scholar 

  49. Huang C, Ma MY, Goranson A, Dong Z. Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis 1999; 20:237–242.

    Article  PubMed  CAS  Google Scholar 

  50. Ragione FD, Cucciolla V, Borriello A et al. Resveratrol arrests the cell division cycle at S/G2 phase transition. Biochem Biophys Res Commun 1998; 250:53–58.

    Article  PubMed  CAS  Google Scholar 

  51. Fontecave M, Lepoivre M, Elleingand E, Gerez C, Guittet O. Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett 1998; 421:277–279.

    Article  PubMed  CAS  Google Scholar 

  52. Sun NJ, Woo SH, Cassady JM, Snapka RM. DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia. J Nat Prod 1998; 61:362–366.

    Article  PubMed  CAS  Google Scholar 

  53. Fukuhara K, Miyata N. Resveratrol as a new type of DNA-cleaving agent. Bioorg Med Chem Lett 1998; 8:3187–3192.

    Article  PubMed  CAS  Google Scholar 

  54. Ciolino HP, Daschner PJ, Yeh GC. Resveratrol inhibits transcription of CYPIA1 in vitro by preventing activation of the aryl hydrocarbon receptor. Cancer Res 1998; 58:5707–5712.

    PubMed  CAS  Google Scholar 

  55. Teel RW, Huynh H. Modulation by phytochemicals of cytochrome P450-linked enzyme activity. Cancer Lett 1998; 133:135–141.

    Article  PubMed  CAS  Google Scholar 

  56. Frotschl R, Chichmanov L, Kleeberg U, Hildebrandt AG, Roots I, Brockmoller J. Prediction of aryl hydrocarbon receptor-mediated enzyme induction of drugs and chemicals by mRNA quantification. Chem Res Toxicol 1998; 11:1447–1452.

    Article  PubMed  CAS  Google Scholar 

  57. Frankel EN, Waterhouse AL, Kinsella JE. Inhibition of human LDL oxidation by resveratrol. Lancet 1993; 341.1103–1104.

    Article  PubMed  CAS  Google Scholar 

  58. Frankel EN, Waterhouse AL, Teissedre PL. Principal phenolic phytochemicals in selected California wines and their antioxidant activity in inhibiting oxidation of human low-density lipoproteins. J Agric Food Chem 1995; 43:890–894.

    Article  CAS  Google Scholar 

  59. Soleas GJ, Tomlinson G, Diamandis EP, Goldberg, DM. Relative contributions of polyphenolic constituents to the antioxidant status of wines: Development of a predictive model. J Agric Food Chem 1997; 45:3995–4003.

    Article  CAS  Google Scholar 

  60. Belguendouz L, Fremont L, Linard A. Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins. Biochem Pharmacol 1997; 53:1347–1355.

    Article  PubMed  CAS  Google Scholar 

  61. Fremont L, Belguendouz L, Delpal S. Antioxidant activity of resveratrol and alcohol-free wine polyphenols related to LDL oxidation and polyunsaturated fatty acids. Life Sci 1999; 64:2511–2521.

    Article  PubMed  CAS  Google Scholar 

  62. Belguendouz L, Fremont L, Gozzelino MT. Interaction of trans-resveratrol with plasma lipoproteins. Biochem Pharmacol 1998; 55:811–816.

    Article  PubMed  CAS  Google Scholar 

  63. Fauconneau B, Waffo-Teguo P, Huguet F, Barrier L, Decendit A, Merillon JM. Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests. Life Sci 1997; 61:2103–2110.

    Article  PubMed  CAS  Google Scholar 

  64. Chanvitayapongs S, Draczynska-Lusiak B, Sun AY. Amelioration of oxidative stress by antioxidants and resveratrol in PC12 cells. Neuroreport 1997; 8:1499–1502.

    Article  PubMed  CAS  Google Scholar 

  65. Draczynska-Lusiak B, Doung A, Sun AY. Oxidized lipoproteins may play a role in neuronal cell death in Alzheimer disease. Mol Chem Neuropathol 1998; 33:139–148.

    Article  PubMed  CAS  Google Scholar 

  66. Jang DS, Kang BS, Ryu SY, Chang 1M, Min KR, Kim Y. Inhibitory effects of resveratrol analogs on unopsonized zymosan-induced oxygen radical production. Biochem Pharmacol 1999; 57:705–712.

    Article  PubMed  CAS  Google Scholar 

  67. Waffo-Teguo P, Fauconneau B, Deffieux G, Huguet F, Vercauteren J, Merillon JM. Isolation, identification, and antioxidant activity of three stilbene glucosides newly extracted from vitis vinifera cell cultures. J Nat Prod 1998; 61:655–657.

    Article  PubMed  Google Scholar 

  68. Shin NH, Ryu SY, Choi EJ, et al. Oxyresvcratrol as the potent inhibitor on dopa oxidase activity of mushroom tyrosinase. Biochem Biophys Res Commun 1998; 243:801–803.

    Article  PubMed  CAS  Google Scholar 

  69. Fitzpatrick DF, Hirschfield SL, Coffey RG. Endothelium-dependent vasorelaxing activity of wine and other grape products. Am J Physiol 1993; 265:H774–H778.

    PubMed  CAS  Google Scholar 

  70. Chen CK, Pace-Asciak CR. Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta. Gen Pharmacol 1996; 27:363–366.

    Article  PubMed  CAS  Google Scholar 

  71. Jager U, Nguyen-Duong H. Relaxant effect of trans-resveratrol on isolated porcine coronary arteries. Arzneimittelforschung 1999; 49:207–211.

    PubMed  CAS  Google Scholar 

  72. Mellanen P, Petanen T, Lehtimaki J, et al. Wood-derived estrogens: studies in vitro with breast cancer cell lines and in vivo in trout. Toxicol Appl Pharmacol 1996; 136:381–388.

    Article  PubMed  CAS  Google Scholar 

  73. Gehm BD, McAndrews JM, Chien PY, Jameson JL. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci USA 1997; 94:14138–14143.

    Article  PubMed  CAS  Google Scholar 

  74. Stahl S, Chun TY, Gray WG. Phytoestrogens act as estrogen agonists in an estrogen-responsive pituitary cell line. Toxicol Appl Pharmacol 1998; 152:41–48.

    Article  PubMed  CAS  Google Scholar 

  75. Lu R, Serrero G. Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells. J Cell Physiol 1999; 179:297–304.

    Article  PubMed  CAS  Google Scholar 

  76. Kopp P. Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the `French paradox’? Eur J Endocrinol 1998; 138:619–620.

    Article  Google Scholar 

  77. Ashby J, Tinwell H, Pennie W, et al. Partial and weak oestrogenicity of the red wine constituent resveratrol: consideration of its superagonist aactivity in MCF-7 cells and its suggested cardiovascular protective effects. J Appl Toxicol 1999; 19:39–45.

    Article  PubMed  CAS  Google Scholar 

  78. Turner RT, Evans GL, Zhang M, Maran A, Sibonga JD. Is resveratrol an estrogen agonist in growing rats? Endocrinology 1999; 140:50–54.

    Article  PubMed  CAS  Google Scholar 

  79. Tham L, Goldberg DM, Diamandis P, Karumanchiri A, Soleas GJ. Extraction of resveratrol from human blood. Clin Biochem 1995; 28:339 (Abst).

    Google Scholar 

  80. Goldberg DM, Tham L, Diamandis EP, Karumanchiri A, Soleas GJ. The assay of resveratrol and its distribution in human blood. Clin Chem 1995; 41:S115 (Abst).

    Google Scholar 

  81. Blache D, Rustan I, Durand P, Lesgards G, Loreau N. Gas chromatographic analysis of resveratrol in plasma, lipoproteins and cells after in vitro incubations. J Chromatogr B Biomed Sci Appl 1997; 702:103–110.

    Article  PubMed  CAS  Google Scholar 

  82. Juan ME, Lamuela-Raventos RM, de la Torre-Boronat MC, Planas JM. Determination of trans-resveratrol in plasma by HPLC. Anal Chem 1999; 71:747750.

    Google Scholar 

  83. Zhu Z, Klironomos G, Vachereau A, Neirinck L, Goodman DW. Determination of trans-resveratrol in human plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 1999; 724:389–392.

    Article  PubMed  CAS  Google Scholar 

  84. Bertelli AA, Giovannini L, Stradi R, Bertelli A, Tillement JP. Plasma, urine and tissue levels of trans-and cis-resveratrol (3,4’,5-trihydroxystilbene) after short-term or prolonged administration of red wine to rats. Int J Tissue React 1996; 18:67–71.

    PubMed  CAS  Google Scholar 

  85. Bertelli AA, Giovannini L, Stradi R, Urien S, Tillement JP, Bertelli A. Kinetics of trans-and cis-resveratrol (3,4’,5-trihydroxystilbene) after red wine oral administration in rats. Int J Clin Pharmacol Res 1996; 16:77–81.

    PubMed  CAS  Google Scholar 

  86. Bertelli A, Bertelli AA, Gozzini A, Giovannini L. Plasma and tissue resveratrol concentrations and pharmacological activity. Drugs Exp Clin Res 1998; 24:133–138.

    PubMed  CAS  Google Scholar 

  87. Orsini F, Pelizzoni F, Bellini B, Miglierini G. Synthesis of biologically active polyphenolic glycosides (combretastatin and resveratrol series). Carbohydr Res 1997; 301:95–109.

    Article  PubMed  CAS  Google Scholar 

  88. Cichewicz RH, Kouzi SA. Biotransformation of resveratrol to piceid by Bacillus cereus. J Nat Prod 1998; 61:1313–1314.

    Article  PubMed  CAS  Google Scholar 

  89. Bertelli AA, Gozzini A, Stradi R, Stella S, Bertelli A. Stability of resveratrol over time and in the various stages of grape transformation. Drugs Exp Clin Res 1998; 24:207–211.

    PubMed  CAS  Google Scholar 

  90. Busam G, Junghanns KT, Kneusel RE, Kassemeyer HH, Matern U. Characterization and expression of caffeoyl-coenzyme A 3–0-methyltransferase proposed for the induced resistance response of Vitis vinifera L. Plant Physiol 1997; 115:1039–1048.

    Article  PubMed  CAS  Google Scholar 

  91. Miloso M, Bertelli AA, Nicolini G, Tredici G. Resveratrol-induced activation of the mitogen-activated protein kinases, ERK1 and ERK2, in human neuroblastoma SHSY5Y cells. Neurosci Lett 1999; 264:141–144.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Quality Assurance, Liquor Control Board of Ontario, Toronto, Ontario, Canada

    George J. Soleas

  2. Department of Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada

    Eleftherios P. Diamandis & David M. Goldberg

  3. Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada

    Eleftherios P. Diamandis

Authors
  1. George J. Soleas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eleftherios P. Diamandis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David M. Goldberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

    Rights and permissions

    Reprints and permissions

    Copyright information

    © 2001 Springer Science+Business Media New York

    About this chapter

    Cite this chapter

    Soleas, G.J., Diamandis, E.P., Goldberg, D.M. (2001). The World of Resveratrol. In: Nutrition and Cancer Prevention. Advances in Experimental Medicine and Biology, vol 492. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1283-7_13

    Download citation

    • DOI: https://doi.org/10.1007/978-1-4615-1283-7_13

    • Publisher Name: Springer, Boston, MA

    • Print ISBN: 978-1-4613-5477-2

    • Online ISBN: 978-1-4615-1283-7

    • eBook Packages: Springer Book Archive

    Publish with us

    Policies and ethics

    Search

    Navigation